{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:13:30Z","timestamp":1790255610064,"version":"4.1.0"},"reference-count":43,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2017,3,23]],"date-time":"2017-03-23T00:00:00Z","timestamp":1490227200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005416","name":"Norges Forskningsr\u00e5d","doi-asserted-by":"publisher","award":["220622\/H10"],"award-info":[{"award-number":["220622\/H10"]}],"id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Liver International"],"published-print":{"date-parts":[[2017,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>In the absence of liver biopsy, the World Health Organization recommends non\u2010invasive tests, such as aspartate aminotransferase to platelet ratio index and <jats:styled-content style=\"fixed-case\">FIB<\/jats:styled-content>\u20104, to assess liver fibrosis in patients with chronic hepatitis B. However, these tests are not well validated in sub\u2010Saharan Africa. Recently, a new marker, gamma\u2010glutamyl transpeptidase to platelet ratio, was found to be more accurate in an African setting, but this needs confirmation in other cohorts.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A treatment program for chronic hepatitis B was initiated in Addis Ababa, Ethiopia, in 2015. Non\u2010invasive tests were compared with transient elastography (Fibroscan 402, Echosense, France) using the following thresholds: no fibrosis (\u22647.9 <jats:styled-content style=\"fixed-case\">kP<\/jats:styled-content>a), significant fibrosis (&gt;7.9 <jats:styled-content style=\"fixed-case\">kP<\/jats:styled-content>a) and cirrhosis (&gt;11.7 <jats:styled-content style=\"fixed-case\">kP<\/jats:styled-content>a). The diagnostic accuracy was estimated by calculating the area under the receiver operating characteristics curve.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of 582 treatment\u2010na\u00efve patients, 141 (24.2%) had significant fibrosis and 90 (15.5%) had cirrhosis. The area under the receiver operating characteristics curve of aspartate aminotransferase to platelet ratio index, <jats:styled-content style=\"fixed-case\">FIB<\/jats:styled-content>\u20104 and gamma\u2010glutamyl transpeptidase to platelet ratio was high both to diagnose significant fibrosis (0.79 [95% <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content> 0.75\u20100.84], 0.79 [95% <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content> 0.75\u20100.84], 0.80 [95% <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content> 0.75\u20100.85]) and cirrhosis (0.86 [95% <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content> 0.81\u20100.91], 0.86 [95% <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content> 0.81\u20100.91], 0.87 [95% <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content> 0.82\u20100.91]). The specificity was high for all tests (94%\u2010100%); however, the sensitivity was poor both to detect fibrosis (10%\u201045%) and cirrhosis (10%\u201036%).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Aspartate aminotransferase to platelet ratio index, <jats:styled-content style=\"fixed-case\">FIB<\/jats:styled-content>\u20104 and gamma\u2010glutamyl transpeptidase to platelet ratio had good diagnostic properties to detect liver fibrosis and cirrhosis in patients with chronic hepatitis B in East Africa. However, the sensitivity was low, and only 10% of patients with cirrhosis were detected using aspartate aminotransferase to platelet ratio index at the World Health Organization recommended threshold.<\/jats:p><\/jats:sec>","DOI":"10.1111\/liv.13393","type":"journal-article","created":{"date-parts":[[2017,2,21]],"date-time":"2017-02-21T16:32:47Z","timestamp":1487694767000},"page":"1461-1467","source":"Crossref","is-referenced-by-count":42,"title":["Are non\u2010invasive fibrosis markers for chronic hepatitis B reliable in sub\u2010Saharan Africa?"],"prefix":"10.1111","volume":"37","author":[{"given":"Hailemichael","family":"Desalegn","sequence":"first","affiliation":[{"name":"Medical Department St. Paul's Hospital Millennium Medical College  Addis Ababa Ethiopia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Aberra","sequence":"additional","affiliation":[{"name":"Medical Department St. Paul's Hospital Millennium Medical College  Addis Ababa Ethiopia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nega","family":"Berhe","sequence":"additional","affiliation":[{"name":"Aklilu Lemma Institute of Pathobiology Addis Ababa University  Addis Ababa Ethiopia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svein G.","family":"Gundersen","sequence":"additional","affiliation":[{"name":"Research Unit S\u00f8rlandet Hospital HF  Kristiansand Norway"},{"name":"Department of Global Development and Planning University of Agder  Kristiansand Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5966-7166","authenticated-orcid":false,"given":"Asgeir","family":"Johannessen","sequence":"additional","affiliation":[{"name":"Centre for Imported and Tropical Diseases Oslo University Hospital  Ullev\u00e5l Oslo Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,3,23]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cld.2009.11.009"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2006.05.013"},{"key":"e_1_2_9_4_1","unstructured":"WHO.Hepatitis B Fact Sheet.2016.http:\/\/www.who.int\/mediacentre\/factsheets\/fs204\/en\/. Accessed December 30 2016."},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23190"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.02.010"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-008-9080-3"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.295.1.65"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.11.016"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510280632"},{"key":"e_1_2_9_11_1","first-page":"192","article-title":"Mortality in patients with Chronic Hepatitis C and cirrhosis compared to the general population \u2010 a Danish cohort study","volume":"215","author":"Hallager S","year":"2017","journal-title":"J Infect Dis"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.10.017"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(86)80075-7"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2008.01802.x"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20506"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2011.05.024"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2010.05.035"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2014.12.014"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-011-1659-1"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2008.03831.x"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0044930"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2013.07.034"},{"key":"e_1_2_9_23_1","unstructured":"WHO.Guidelines for the Prevention Care and Treatment of Persons with Chronic Hepatitis B Infection.Geneva:World Health Organization;2015."},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1017\/CBO9780511751660.068"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-309260"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2010.09-0088"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0022291"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268803008574"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/0035-9203(95)90482-4"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.1890240110"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2003.50346"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21178"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.2307\/2531595"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-138-1-200301070-00010"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27382"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003372"},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2016-312658"},{"key":"e_1_2_9_38_1","unstructured":"MoH.National guideline for prevention and control of viral hepatitis in Ethiopia.Addis Ababa:Ethiopian Ministry of Health;2016."},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2011.06.036"},{"key":"e_1_2_9_40_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1746.2000.0150121356.x"},{"key":"e_1_2_9_41_1","doi-asserted-by":"publisher","DOI":"10.1080\/00365520310000825"},{"key":"e_1_2_9_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2008.11.029"},{"key":"e_1_2_9_43_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12561"},{"key":"e_1_2_9_44_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-010-9189-z"}],"container-title":["Liver International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fliv.13393","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/liv.13393","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T12:50:52Z","timestamp":1753188652000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/liv.13393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,23]]},"references-count":43,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["10.1111\/liv.13393"],"URL":"https:\/\/doi.org\/10.1111\/liv.13393","archive":["Portico"],"relation":{},"ISSN":["1478-3223","1478-3231"],"issn-type":[{"value":"1478-3223","type":"print"},{"value":"1478-3231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,23]]}}}